IL-6 blockade in the management of non-infectious uveitis Giuseppe LopalcoClaudia FabianiLuca Cantarini Review Article 20 May 2017 Pages: 1459 - 1469
Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient survey Morgan SchultzStephanie O. KeelingJill J. Hall Original Article 27 May 2017 Pages: 1471 - 1478
Association of tumor necrosis factor–α (G-308A) genetic variant with matrix metalloproteinase–9 activity and joint destruction in early rheumatoid arthritis Sonja StojanovicBojana StamenkovicDusica Pavlovic Original Article 01 June 2017 Pages: 1479 - 1485
Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays Ine VosChristof Van MolTom W. Huizinga Original Article Open access 03 June 2017 Pages: 1487 - 1492
Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis Jorge Rojas-SerranoDenisse Herrera-BringasMayra Mejía Original Article 06 June 2017 Pages: 1493 - 1500
Prevalence of hearing impairment in patients with rheumatoid arthritis, granulomatosis with polyangiitis (GPA, Wegener’s granulomatosis), or systemic lupus erythematosus Torsten RahneFranziska ClaußGernot Keyßer Original Article 28 April 2017 Pages: 1501 - 1510
The relationship between disease activity, quality of life, and personality types in rheumatoid arthritis and ankylosing spondylitis patients T. DonisanV. C. BojincăA. R. Bălănescu Original Article 27 April 2017 Pages: 1511 - 1519
Gastrointestinal system manifestations in juvenile systemic lupus erythematosus Hafize Emine SönmezAsuman Nur KarhanSeza Özen Original Article 16 February 2017 Pages: 1521 - 1526
Prevalence and features of metabolic syndrome in childhood-onset systemic lupus erythematosus Nailú Angélica SinicatoMariana PostalSimone Appenzeller Original Article 19 April 2017 Pages: 1527 - 1535
Prevalence of HLA-B27 in the general population and in patients with axial spondyloarthritis in Saudi Arabia Mohammed A. OmairFatmah K. AlDuraibiMoheeb Al Awwami Original Article 29 April 2017 Pages: 1537 - 1543
Magnetic resonance imaging in diffuse idiopathic skeletal hyperostosis: similarities to axial spondyloarthritis Uri AradOri ElkayamIris Eshed Original Article 31 March 2017 Pages: 1545 - 1549
Assessment of typical SpA lesions on MRI of the spine: do local readers and central readers agree in the DESIR-cohort at baseline? Manouk de HoogeJean-Baptiste PialatAntoine Feydy Original Article 23 May 2017 Pages: 1551 - 1559
Clinical patterns and characteristics of ankylosing spondylitis in China Qiaoxia QianXia XuJiucun Wang Original Article 27 May 2017 Pages: 1561 - 1568
Indirect comparisons of the efficacy of biological agents in patients with active ankylosing spondylitis: a systematic review and meta-analysis Patompong UngprasertPatricia J. ErwinMatthew J. Koster Original Article 28 May 2017 Pages: 1569 - 1577
Economic impact of biologic utilization patterns in patients with psoriatic arthritis Sergio SchwartzmanYunfeng LiJacqueline B. Palmer Original Article Open access 04 May 2017 Pages: 1579 - 1588
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study Maddalena NapolitanoLuisa CostaAnna Balato Original Article 31 May 2017 Pages: 1589 - 1593
Seasonal variations of urate in a Swedish adult population Axel ÅkerblomJohanna Helmersson-KarlqvistAnders Larsson Original Article Open access 10 March 2017 Pages: 1595 - 1598
The added value of synovial fluid centrifugation for monosodium urate and calcium pyrophosphate crystal detection D. BoumansM. E. HettemaM. A. van de Laar Original Article 19 April 2017 Pages: 1599 - 1605
An evidence-based walking program among older people with knee osteoarthritis: the PEP (participant exercise preference) pilot randomized controlled trial Laurianne LoewLucie BrosseauGeorge A. Wells Original Article 22 March 2017 Pages: 1607 - 1616
Fibromyalgia in patients with thyroid autoimmunity: prevalence and relationship with disease activity Sema HalilogluBilge EkinciPinar Mazlum Macit Original Article 07 February 2017 Pages: 1617 - 1621
The placebo effect and its determinants in fibromyalgia: meta-analysis of randomised controlled trials Xi ChenKun ZouWeiya Zhang Original Article Open access 15 March 2017 Pages: 1623 - 1630
Improving skills in pediatric rheumatology in Colombia: a combined educational strategy supported by ILAR Sally PinoClaudia MoraDiego Jaimes Original Article 17 May 2016 Pages: 1631 - 1635
Primary Raynaud’s phenomenon and nailfold videocapillaroscopy: age-related changes in capillary morphology Carmen PizzorniAlberto SulliSabrina Paolino Brief Report 08 October 2016 Pages: 1637 - 1642
Validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0 in English- and Chinese-speaking patients in a multi-ethnic Singapore systemic sclerosis cohort Andrea Hsiu Ling LowXiaohui XinJulian Thumboo Brief Report 05 January 2017 Pages: 1643 - 1648
CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis Alain LescoatValérie LecureurPatrick Jégo Brief Report 14 March 2017 Pages: 1649 - 1654
Association of anti-triosephosphate isomerase antibodies with aseptic meningitis in patients with neuropsychiatric systemic lupus erythematosus Shuzo SatoMakiko YashiroKiyoshi Migita Brief Report 28 April 2017 Pages: 1655 - 1659
NLRP12 autoinflammatory disease: a Chinese case series and literature review Min ShenLin TangQingping Yao Brief Report 16 September 2016 Pages: 1661 - 1667
Culture, PCR, DNA sequencing, and second harmonic generation (SHG) visualization of Bartonella henselae from a surgically excised human femoral head M. EricsonN. BalakrishnanE. B. Breitschwerdt Brief Report 27 December 2016 Pages: 1669 - 1675
Recurrent infections in a patient with psoriatic arthritis and hypogammaglobulinemia, treated with conventional and biologic disease-modifying anti-rheumatic drugs—a primary or secondary entity? Ewa Więsik-SzewczykAleksandra KucharczykKarina Jahnz-Różyk Case Based Review 09 May 2017 Pages: 1677 - 1681
“Hiker’s feet”: a novel cutaneous finding in the inflammatory myopathies Jacob T. CoxDavid M. GullottiLisa Christopher-Stine Case Based Review 07 April 2017 Pages: 1683 - 1686
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature Stefano GentileschiDonato RiganteLuca Cantarini Case Based Review 23 May 2017 Pages: 1687 - 1690
Response to “Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial” David Hawkes Letter to the Editor 25 March 2017 Pages: 1691 - 1692
Voriconazole-induced periostitis vs. hypertrophic osteoarthropathy Carlos PinedaManuel Martínez-Lavín Letter to the Editor 08 April 2017 Pages: 1693 - 1694
Presidents’ Day reflections. Why Donald Trump could not be a rheumatologist Richard S. PanushEric L. Matteson Letter to the Editor 12 April 2017 Pages: 1695 - 1696
Erratum to: Predictors of poor sleep quality in patients with systemic lupus erythematosus M. InoueK. ShiozawaK. Makimoto Erratum 03 May 2017 Pages: 1697 - 1698